Transaction in Own Shares

Summary by AI BETAClose X

On October 14, 2025, GSK plc, acting through BNP Paribas SA, purchased 270,000 of its own ordinary shares with a nominal value of 31¼ pence each. The shares were bought at prices ranging from 1,625.50p to 1,649.00p per share, with a volume-weighted average price of 1,641.67p. These shares will be held as treasury shares as part of an existing buyback program. Since September 30, 2025, GSK has purchased a total of 3,514,000 ordinary shares. Following this transaction, GSK holds 250,978,844 ordinary shares in treasury and has 4,064,434,985 ordinary shares in issue, excluding treasury shares; the percentage of voting rights attributable to treasury shares is 6.17 percent.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings